These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7862388)

  • 1. Universal screening for group B streptococcus: recommendations and obstetricians' practice decisions.
    Gigante J; Hickson GB; Entman SS; Oquist NL
    Obstet Gynecol; 1995 Mar; 85(3):440-3. PubMed ID: 7862388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetricians' compliance with CDC guidelines on maternal screening and intrapartum prophylaxis for group B streptococcus.
    Mahieu LM; De Dooy JJ; Leys E
    J Obstet Gynaecol; 2000 Sep; 20(5):460-4. PubMed ID: 15512626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(28):701-5. PubMed ID: 17637595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the barriers to offering HIV testing in an antenatal setting? A national study of obstetricians.
    Giles ML; Garland SM; Lewin SR; Hellard ME
    AIDS; 2007 Jul; 21(12):1601-6. PubMed ID: 17630555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening.
    El Helali N; Nguyen JC; Ly A; Giovangrandi Y; Trinquart L
    Clin Infect Dis; 2009 Aug; 49(3):417-23. PubMed ID: 19580414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of different prevention strategies on neonatal group B streptococcal disease.
    Vergani P; Patanè L; Colombo C; Borroni C; Giltri G; Ghidini A
    Am J Perinatol; 2002 Aug; 19(6):341-8. PubMed ID: 12357426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
    Konrad G; Katz A
    Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in universal prenatal screening for group B streptococcus--North Carolina, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(28):700-3. PubMed ID: 16034316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory practices for prenatal Group B streptococcal screening and reporting--Connecticut, Georgia, and Minnesota, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(20):426-8. PubMed ID: 10365633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes.
    Glass NE; Schulkin J; Chamany S; Riley LE; Schuchat A; Schrag S
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):5-10. PubMed ID: 16040321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness, knowledge and attitudes of lead maternity carers towards early-onset neonatal group B streptococcal disease.
    Gosling I; Stone P; Grimwood K
    N Z Med J; 2002 Mar; 115(1149):106-8. PubMed ID: 11999221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of group B streptococcal disease in the newborn.
    Apgar BS; Greenberg G; Yen G
    Am Fam Physician; 2005 Mar; 71(5):903-10. PubMed ID: 15768620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(11):228-32. PubMed ID: 10763673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit.
    Angstetra D; Ferguson J; Giles WB
    Aust N Z J Obstet Gynaecol; 2007 Oct; 47(5):378-82. PubMed ID: 17877594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
    Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
    J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture-based group B streptococcal screening. Adherence to current guidelines.
    Pinette MG; Wax JR; Blackstone J; Cartin A; McCrann DJ
    J Reprod Med; 2003 May; 48(5):309-12. PubMed ID: 12815900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B streptococcus disease in neonates: to screen or not to screen?
    Subair O; Wagner P; Omojole F; Morgan H
    J Obstet Gynaecol; 2005 Jul; 25(5):462-4. PubMed ID: 16183581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors and screening strategy for group B streptococcal colonization in pregnant women: results of a prospective study].
    Jauréguy F; Carton M; Teboul J; Butel MJ; Panel P; Ghnassia JC; Doucet-Populaire F
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):132-8. PubMed ID: 12717304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Real World" compliance with strategies to prevent early-onset group B streptococcal disease.
    Riley L; Appollon K; Haider S; Chan-Flynn S; Cohen A; Ecker J; Rein M; Lieberman E
    J Perinatol; 2003 Jun; 23(4):272-7. PubMed ID: 12774132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.